Momo Medical vs Armilla AI
Side-by-side comparison of AI visibility scores, market position, and capabilities
AI bed sensor system for nursing homes preventing pressure ulcers with 30% care efficiency improvement; $8.89M Series A from PGGM serving 250 facilities across Netherlands, Germany, and US.
About
Momo Medical is a medical technology company developing AI-powered bed sensor systems for nursing homes that monitor patient position and mobility — detecting when nursing home residents have been in the same position for too long (increasing pressure ulcer risk) and alerting care staff with optimal repositioning recommendations, making nursing care more proactive and efficient. Founded in the Netherlands and backed by Y Combinator, Momo Medical raised $9 million total including an $8.89 million Series A led by PGGM (a Dutch pension fund manager) in August 2024.\n\nMomo Medical's under-mattress sensor pad continuously monitors patient position without requiring wearables or cameras, providing pressure distribution data and movement detection that feeds into an AI system. The system learns each patient's typical movement patterns and identifies deviations that may indicate clinical concerns. For nursing staff, Momo provides a dashboard showing all patients' positioning status, flagging who needs repositioning, and eliminating the need for manual turn schedules (which are often missed during busy shifts). The company claims a 30% improvement in nursing staff effectiveness through reduction of unnecessary rounds and better-timed interventions.\n\nIn 2025, Momo Medical serves 250 nursing home locations across the Netherlands, Germany, Canada, and the United States, with 246% revenue growth in 2023 demonstrating strong market pull. The company competes in the elder care monitoring space with EarlySense (bed sensor for acute care), Oxevision (optical monitoring), and various wearable patient monitoring solutions for nursing home safety and care efficiency. Pressure ulcers are one of the most prevalent and preventable nursing home complications, costing healthcare systems billions annually. The PGGM backing is strategically significant — PGGM manages pension funds for Dutch healthcare workers, creating a natural distribution channel through the Dutch healthcare system. The 2025 strategy focuses on scaling across more European nursing home networks and growing the North American presence.
AI quality assurance with insurance-backed warranties from Swiss Re and Greenlight Re; EU AI Act compliance assessments backed by YC and reinsurance partners for high-risk AI deployments.
About
Armilla AI is a third-party AI quality assurance and warranty company that evaluates AI models for organizations deploying AI in regulated or high-stakes contexts — assessing models against EU AI Act and NIST AI Risk Management Framework requirements for risks including bias, hallucination, robustness failures, and adversarial vulnerabilities, then providing performance guarantees backed by insurance coverage from reinsurers Swiss Re, Greenlight Re, and Chaucer. Founded in Toronto, Canada, Armilla raised $6.81 million total including a C$4.5 million seed round in February 2024 from Mistral Venture Partners, MS&AD Ventures, Y Combinator, and its reinsurance partners.\n\nArmilla's model is unique in the AI governance market — rather than just providing compliance reports, Armilla backs its assessments with insurance warranty products. An enterprise deploying a third-party AI model can purchase an Armilla warranty that pays out if the model performs differently than assessed (fails on bias, accuracy, or robustness metrics), transferring AI performance risk to insurance markets that can price and distribute it. This insurance mechanism creates financial accountability for AI quality claims that audit reports alone don't provide.\n\nIn 2025, Armilla competes in the AI governance, risk, and compliance market with Credo AI, Arthur AI, and AI audit firms for enterprise AI risk assessment and compliance tools. The EU AI Act, fully applicable by August 2025 for high-risk AI systems, is driving enterprise compliance urgency — companies deploying AI in hiring, credit scoring, healthcare, and other regulated contexts need third-party conformity assessments. Armilla's insurance-backed warranty differentiates its offering from pure advisory competitors. The reinsurer backing (Swiss Re, Greenlight Re, Chaucer) provides both capital credibility and distribution through insurance broker channels. The 2025 strategy focuses on growing EU AI Act compliance assessments and expanding the warranty product coverage to more AI deployment use cases.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.